126 related articles for article (PubMed ID: 15174097)
1. Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma.
Altomonte M; Visintin A; Tecce R; Leonardi A; Calabro L; Fonsatti E; Pucillo C; Maio M
J Cell Physiol; 2004 Aug; 200(2):272-6. PubMed ID: 15174097
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
Altomonte M; Fonsatti E; Visintin A; Maio M
Oncogene; 2003 Sep; 22(42):6564-9. PubMed ID: 14528281
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells.
Aoudjit F; Guo W; Gagnon-Houde JV; Castaigne JG; Alcaide-Loridan C; Charron D; Al-Daccak R
Exp Cell Res; 2004 Sep; 299(1):79-90. PubMed ID: 15302575
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase mediates human leukocyte histocompatibility antigen class II-induced signaling in gingival fibroblasts.
Yoshizawa S; Meguro M; Ohyama H; Takeuchi-Hatanaka K; Matsushita S; Takashiba S; Nishimura F
J Periodontal Res; 2007 Dec; 42(6):572-9. PubMed ID: 17956472
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
6. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
7. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
[TBL] [Abstract][Full Text] [Related]
8. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
9. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules.
Chiari R; Hames G; Stroobant V; Texier C; Maillère B; Boon T; Coulie PG
Cancer Res; 2000 Sep; 60(17):4855-63. PubMed ID: 10987298
[TBL] [Abstract][Full Text] [Related]
10. Effect of ligand conformation on melanoma cell alpha3beta1 integrin-mediated signal transduction events: implications for a collagen structural modulation mechanism of tumor cell invasion.
Lauer JL; Gendron CM; Fields GB
Biochemistry; 1998 Apr; 37(15):5279-87. PubMed ID: 9548759
[TBL] [Abstract][Full Text] [Related]
11. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
Altomonte M; Pucillo C; Damante G; Maio M
J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
[TBL] [Abstract][Full Text] [Related]
12. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
13. Effects of human leukocyte antigen (HLA)-DR engagement on melanoma cells.
Barbieri G; Rimini E; Costa MA
Int J Oncol; 2011 Jun; 38(6):1589-95. PubMed ID: 21455572
[TBL] [Abstract][Full Text] [Related]
14. Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturation.
Coral S; Pucillo C; Leonardi A; Fonsatti E; Altomonte M; Maio M
Cell Growth Differ; 1997 May; 8(5):581-8. PubMed ID: 9149909
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the tyrosine kinase-dependent adhesion pathway in human lymphocytes through CD45.
Wagner N; Engel P; Tedder TF
J Immunol; 1993 Jun; 150(11):4887-99. PubMed ID: 7684415
[TBL] [Abstract][Full Text] [Related]
16. MHC class II isotype-specific signaling complex on human B cells.
Lévéille C; Castaigne JG; Charron D; Al-Daccak R
Eur J Immunol; 2002 Aug; 32(8):2282-91. PubMed ID: 12209641
[TBL] [Abstract][Full Text] [Related]
17. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
18. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation.
Bian H; Harris PE; Mulder A; Reed EF
Hum Immunol; 1997 Mar; 53(1):90-7. PubMed ID: 9127152
[TBL] [Abstract][Full Text] [Related]
19. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
20. pp125FAK in human melanocytes and melanoma: expression and phosphorylation.
Scott G; Liang H
Exp Cell Res; 1995 Jul; 219(1):197-203. PubMed ID: 7543052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
